“Platelet Activating Factor Receptor Antagonists Improve the Efficacy of Experimental Chemo- and Radiotherapy”. Clinics, vol. 73, no. Suppl. 1, Feb. 2019, p. e792s, https://doi.org/10.6061/clinics/2018/e792s.